CATHETER-RELATED SUPERIOR VENA CAVA THROMBOSIS IN HEMODIALYSIS: A CASE OF A LIFE-THREATENING CENTRAL VENOUS OBSTRUCTION

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/2bd6395d20e57e677965b21a51c62e3d.pdf
CATHETER-RELATED SUPERIOR VENA CAVA THROMBOSIS IN HEMODIALYSIS: A CASE OF A LIFE-THREATENING CENTRAL VENOUS OBSTRUCTION

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
APRIL
LEGASPI
APRIL LEGASPI gig2legaspi@yahoo.com Perpetual Succour Hospital Nephrology Cebu City Philippines *
RUBEN MAGUAD rumagmd@gmail.com Perpetual Succour Hospital Nephrology Cebu City Philippines -
GRECIA DARUNDAY grecia.darunday@yahoo.com Perpetual Succour Hospital Nephrology Cebu City Philippines -
-
-
-
-
-
-
-
-
-
-
-
-

Central venous catheters remain an indispensable modality of vascular access in patients undergoing maintenance hemodialysis, especially when permanent access is unavailable or other vascular access have failed. However, they are associated with serious complications, including central vein thrombosis. Superior vena cava (SVC) thrombosis is a rare but potentially life-threatening and may result in SVC syndrome causing airway obstruction, cerebral edema, increased intracranial pressure and pulmonary embolism.


Figure 1. Clinical photograph of the patient showing marked facial edema particularly involving the left periorbital and submandibular regions with visible neck vein distention. The swelling was more pronounced on the left side consistent with venous congestion. We describe a 48-year-old male with end-stage-renal disease via a left internal jugular non tunneled dialysis catheter. The catheter was removed due to candidemia and the patient was placed on a seven-day catheter holiday. Subsequently, he developed progressive facial swelling, neck vein distention and dyspnea. Contrast-enhanced chest CT revealed extensive thrombus involving the left innominate vein and superior vena cava. 

Figure 2. Contrast-enhanced CT scan of the chest, coronal view showing a non-occlusive mural thrombus (red arrow) within the superior vena cava, extending to the junction of the left innominate vein, measuring 5.7 cm x 1.4 cm x 0.7 cm (cephalocaudal, AP, transverse).

 This findings showed that a mural thrombus is formed due to endothelial damage brought about by catheter-induced trauma causing vascular stasis and thrombus formation as exemplified by Virchow’s triad. Anticoagulation with unfractionated heparin was initiated and continued for 7 days then bridged with Warfarin. This was followed by marked improvement of the patient’s clinical condition. Hemodialysis was resumed through a newly inserted femoral catheter. Warfarin was maintained as outpatient with target INR between 2-3 and he remains in good clinical condition without bleeding complications. Future vascular access planning was also undertaken.

This case underscores the importance of recognizing central venous thrombosis as a potentially fatal complication of internal jugular catheter use in hemodialysis. Prompt identification through clinical assessment and imaging facilitates timely intervention. Thrombolysis constitutes the cornerstone of therapy.

Kewords